Karen Akinsanya is a director of Nautilus Biotechnology Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Schrodinger, Inc.
5 Mar 24
4
Nautilus Biotechnology, Inc.
16 Jun 23
4
Schrodinger, Inc.
10 Feb 23
4
Nautilus Biotechnology, Inc.
16 Jun 22
4
Nautilus Biotechnology, Inc.
31 Mar 22
3
Nautilus Biotechnology, Inc.
31 Mar 22
4
Schrodinger, Inc.
9 Feb 22
4
Schrodinger, Inc.
19 Oct 21
4
Schrodinger, Inc.
16 Sep 21
4
Schrodinger, Inc.
17 Aug 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 24 | SDGR Schrodinger | Stock Option Common Stock | Grant | Acquire A | No | No | 25.24 | 120,000 | 3.03 mm | 120,000 |
15 Jun 23 | NAUT Nautilus Biotechnology | Stock Option Common Stock | Grant | Acquire A | No | No | 3.97 | 45,000 | 178.65 k | 45,000 |
9 Feb 23 | SDGR Schrodinger | Stock Option Common Stock | Grant | Acquire A | No | No | 23.29 | 63,270 | 1.47 mm | 63,270 |